Off-Label Use of Antineoplastic Drugs to Treat Malignancies: Evidence From China Based on a Nationwide Medical Insurance Data Analysis

Off-Label Use of Antineoplastic Drugs to Treat Malignancies: Evidence From China Based on a Nationwide Medical Insurance Data Analysis

Purpose: Cancer is a leading cause of morbidity and mortality worldwide. Off-label (OL) use of antineoplastic drugs to treat malignancies is prevalent. In this study, we quantified and characterized OL use of antineoplastic drugs to treat malignancies in China.Methods: This was a retrospective study...

Full description

Bibliographic Details
Main Authors: Guoxu Wei, Min Wu, He Zhu, Sheng Han, Jing Chen, Chenchen Zhai, Luwen Shi
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Pharmacology
Subjects:
off-label use
antineoplastic drugs
malignancies
nationwide medical insurance data
retrospective study
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.616453/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.616453/full

Similar Items